- Home
- REVB vs UGRO Comparison
REVB vs UGRO Comparison
Compare REVB & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REVB
- UGRO
- Stock Information
- Founded
- REVB 2020
- UGRO 2014
- Country
- REVB United States
- UGRO United States
- Employees
- REVB N/A
- UGRO N/A
- Industry
- REVB Biotechnology: Pharmaceutical Preparations
- UGRO Industrial Specialties
- Sector
- REVB Health Care
- UGRO Consumer Discretionary
- Exchange
- REVB Nasdaq
- UGRO Nasdaq
- Market Cap
- REVB 4.4M
- UGRO 3.8M
- IPO Year
- REVB N/A
- UGRO N/A
- Fundamental
- Price
- REVB $2.87
- UGRO $0.49
- Analyst Decision
- REVB
- UGRO Strong Buy
- Analyst Count
- REVB 0
- UGRO 1
- Target Price
- REVB N/A
- UGRO $3.00
- AVG Volume (30 Days)
- REVB 87.7K
- UGRO 17.6M
- Earning Date
- REVB 11-07-2025
- UGRO 10-30-2025
- Dividend Yield
- REVB N/A
- UGRO N/A
- EPS Growth
- REVB N/A
- UGRO N/A
- EPS
- REVB N/A
- UGRO N/A
- Revenue
- REVB N/A
- UGRO $59,985,138.00
- Revenue This Year
- REVB N/A
- UGRO N/A
- Revenue Next Year
- REVB N/A
- UGRO $31.25
- P/E Ratio
- REVB N/A
- UGRO N/A
- Revenue Growth
- REVB N/A
- UGRO N/A
- 52 Week Low
- REVB $2.11
- UGRO $0.26
- 52 Week High
- REVB $60.48
- UGRO $1.92
- Technical
- Relative Strength Index (RSI)
- REVB 56.54
- UGRO 56.42
- Support Level
- REVB $2.65
- UGRO $0.39
- Resistance Level
- REVB $2.88
- UGRO $0.79
- Average True Range (ATR)
- REVB 0.19
- UGRO 0.07
- MACD
- REVB 0.03
- UGRO 0.01
- Stochastic Oscillator
- REVB 88.00
- UGRO 32.05
About REVB Revelation Biosciences Inc.
Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).
About UGRO urban-gro Inc.
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.